Diaceutics Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	10.38	12.74	16.67	19.84	19.68	25.26
Cash & Short-Term Investments	10.38	12.74	16.67	19.84	19.68	25.26
Cash Growth	-38.00%	-23.54%	-16.00%	0.84%	-22.10%	115.49%
Accounts Receivable	11.37	14.81	9.83	8.37	7	5.34
Other Receivables	0.9	0.89	0.3	2.05	2.92	2.43
Receivables	12.26	15.7	10.13	10.43	9.92	7.78
Prepaid Expenses	1.18	1.08	1.24	0.63	0.43	0.59
Other Current Assets	0.64	-	-	-	0.04	-
Total Current Assets	24.46	29.53	28.04	30.9	30.06	33.62
Property, Plant & Equipment	1.71	1.68	1.9	2.09	2.13	0.24
Other Intangible Assets	15.36	15.41	15.26	15.04	12.61	8.94
Long-Term Deferred Tax Assets	2.89	2	1.14	0.05	0	0.3
Long-Term Deferred Charges	-	-	-	0.18	0.22	0.42
Total Assets	44.42	48.62	46.34	48.26	45.01	43.52
Accounts Payable	1.07	1.22	1.07	0.76	0.51	0.47
Accrued Expenses	2.83	5.05	2.26	2	1.31	1.58
Short-Term Debt	-	-	-	-	0.13	0.12
Current Portion of Leases	0.23	0.15	0.15	0.12	0.15	-
Current Income Taxes Payable	0.43	0.47	0.47	0.42	0.33	0.45
Current Unearned Revenue	1.45	0.34	0.41	0.41	0.21	0.3
Other Current Liabilities	0.18	0.54	0.04	0.04	-	-
Total Current Liabilities	6.18	7.77	4.38	3.75	2.63	2.92
Long-Term Leases	0.91	0.91	1.06	1.21	1.29	-
Long-Term Deferred Tax Liabilities	-	-	0.03	0.71	0.45	0.37
Other Long-Term Liabilities	0.09	0.09	0.09	0.08	-	-
Total Liabilities	7.18	8.76	5.56	5.74	4.36	3.28
Common Stock	0.17	0.17	0.17	0.17	0.17	0.17
Additional Paid-In Capital	-	-	37.13	37.13	36.86	36.86
Retained Earnings	38.65	40.63	4.04	5.34	4.08	3.19
Treasury Stock	-0.31	-0.31	-0.31	-0.26	-0.17	-
Comprehensive Income & Other	-1.27	-0.63	-0.24	0.14	-0.3	0.02
Shareholders' Equity	37.24	39.86	40.79	42.51	40.65	40.24
Total Liabilities & Equity	44.42	48.62	46.34	48.26	45.01	43.52
Total Debt	1.13	1.06	1.21	1.33	1.56	0.12
Net Cash (Debt)	9.25	11.68	15.46	18.51	18.11	25.14
Net Cash Growth	-40.76%	-24.43%	-16.48%	2.20%	-27.94%	116.47%
Net Cash Per Share	0.11	0.14	0.18	0.22	0.21	0.32
Filing Date Shares Outstanding	84.56	84.52	84.25	84.26	83.94	84.07
Total Common Shares Outstanding	84.56	84.52	84.25	84.26	83.94	84.07
Working Capital	18.28	21.76	23.66	27.14	27.43	30.7
Book Value Per Share	0.44	0.47	0.48	0.50	0.48	0.48
Tangible Book Value	21.88	24.44	25.52	27.47	28.04	31.3
Tangible Book Value Per Share	0.26	0.29	0.30	0.33	0.33	0.37
Machinery	0.88	0.83	0.73	0.62	0.48	0.4
Leasehold Improvements	0.53	0.53	0.53	0.53	0.48	-
Order Backlog	-	24.93	26.52	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.